Technical Analysis for MCRB - Seres Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 3.46 -0.57% -0.02
MCRB closed down 0.57 percent on Friday, October 18, 2019, on 60 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical MCRB trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Doji - Bearish? Reversal 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
20 DMA Resistance Bearish -0.57%
50 DMA Resistance Bearish -0.57%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.57%

Older signals for MCRB ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Seres Therapeutics, Inc., a microbiome therapeutics platform company, focuses on the development of biological drugs designed to restore health by repairing the function of a dysbiotic microbiome. Its lead product candidate is SER-109, a bacterial spore ecology, which has completed open label Phase Ib/2 clinical study for the prevention of further recurrences of Clostridium difficile infection (CDI). The company's product candidates in pre-clinical development comprise SER-262, an Ecobiotic microbiome therapeutic designed to be used following antibiotic treatment of primary CDI to prevent the initial recurrence of CDI; SER-287 to treat inflammatory bowel disease, including ulcerative colitis; and SER-155 to treat enteric pathogens, such as antibiotic-resistant bacteria. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Medicine Medical Specialties Autoimmune Diseases Inflammatory Bowel Disease Ulcerative Colitis Diarrhea Antimicrobial Resistance Digestive Diseases Clostridioides Difficile Clostridium Difficile Infection
Is MCRB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.0
52 Week Low 2.02
Average Volume 350,786
200-Day Moving Average 4.5916
50-Day Moving Average 3.5434
20-Day Moving Average 3.475
10-Day Moving Average 3.194
Average True Range 0.2372
ADX 19.87
+DI 23.5344
-DI 24.2032
Chandelier Exit (Long, 3 ATRs ) 3.4352
Chandelier Exit (Short, 3 ATRs ) 3.5766
Upper Bollinger Band 4.2084
Lower Bollinger Band 2.7416
Percent B (%b) 0.49
BandWidth 42.210072
MACD Line -0.0924
MACD Signal Line -0.101
MACD Histogram 0.0086
Fundamentals Value
Market Cap 140.17 Million
Num Shares 40.5 Million
EPS -2.42
Price-to-Earnings (P/E) Ratio -1.43
Price-to-Sales 17.96
Price-to-Book 4.50
PEG Ratio 0.03
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.82
Resistance 3 (R3) 3.83 3.73 3.76
Resistance 2 (R2) 3.73 3.63 3.72 3.74
Resistance 1 (R1) 3.59 3.58 3.58 3.58 3.72
Pivot Point 3.49 3.49 3.48 3.48 3.49
Support 1 (S1) 3.35 3.39 3.34 3.34 3.20
Support 2 (S2) 3.25 3.34 3.24 3.18
Support 3 (S3) 3.11 3.25 3.16
Support 4 (S4) 3.10